Documents

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 July 2024)

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 June 2024)

Challenges and possible options when designing a Platform Trial - F. Houyez (EURORDIS)

Challenges in performing mult-country Investigator Initiated Trials in EU - M. Zuidgeest (UMC Utrecht)

CTA review process and CTR implementation - L. Leyens (EFPIA)

Enabling CTIS Public Data Use - F. Sweeney (CDDF)

Enhancing and harmonizing Regulatory process for clinical trials- M. Heath (Vaccines Europe)

Innovative Study Designs in Paediatrics - D. Bonifazi (TEDDY)

Limited Scientific advice for academic developers - D. Coppens (KWF)

Low-intervention clinical trials - S. Kromar (EORTC)

Paediatric patients involvement in the drug development - B. Nafria (eYPAGnet)

Presentation of ACT EU workplan and deliverables - L. Pioppo (EMA)

Presentation of ACT EU workplan and deliverables - A. Zanoletty (EMA), L. Pioppo (EMA)

Report on the 2023 survey on the implementation of the Clinical Trials Regulation

MSP Advisory Group Agenda 04 July 2024

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 May 2024)

Guidance for applicants SAWP CTCG pilot on scientific advice (Version 2)

Guidance for applicants pre-CTA advice pilot (Version 2)

MSP Advisory group and MSP annual meeting dates 2024-2026

This document outlines the 2024-2026 meeting dates for the MSP Advisory group and the MSP annual meetings.

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 April 2024)

Minutes of Meeting - Informative session for ad hoc representatives of MSP Advisory Group 11 April 2024